|CD International Enterprises, Inc. (CDII) Leveraging Experience and Relationships to Capitalize on Opportunity|
For over a decade, multi-faceted CD International Enterprises, Inc. (OTC: CDII) has successfully sourced and distributed industrial commodities such as iron ore, manganese ore, and scrap metals for delivery to businesses in the People’s Republic of China. In fact, the company recently announced that it has entered into a letter of intent with a Honduras-based company to purchase 1.2 million metric tons of iron ore over a 12-month period (http://dtn.fm/yOQ70). The initial 12-month contract of 1.2 million metric tons of iron ore values at approximately $84 million on basis of the current CIF China price. In addition, the monthly supply can be increased to 500,000 metric tons per month, or six million metric tons of iron ore per year.
Leveraging commodities sourcing as a liaison between three continents, CD International has established strong relationships in South America, North America and Asia. These relationships have provided the company opportunities to expand its business services to suppliers and purchasers to include financing, logistics, quality control and legal due diligence, as well as providing consultation services and guidance for Chinese entities to compete in a complex global economy. The company’s wide-ranging services made it a one-stop-shop for international companies looking to leverage global market opportunities.
Always on the lookout for exceptional global market opportunities itself, CD International recently undertook a new enterprise and formed a new division to profit from one of the fastest-growing market categories in the world. The company formed its Green Products division and online retail store (http://www.greencbdproducts.com/cbd) to distribute and sell medicinal cannabidiol (CBD) based products to the 2+ billion Chinese-speaking people located around the globe. Non-euphoric CBD-based products have a broad range of therapeutic uses, including treating epilepsy, anxiety, pain and nausea. CBD oil is legal in all 50 U.S. states and can be exported to over 40 countries including China, and CBD-based products have a projected 60 percent annual growth rate.
The company’s extensive international experience and relationships have given it a unique ability to identify and capitalize on emerging global market opportunities. The company has an abundant knowledge of the innate practices of the Chinese consumer and Chinese commerce, which gives it competitive advantages in this fast-developing global market. CBD-based products fit well with traditional Chinese holistic medicine, and the company believes the demand in Chinese-speaking communities for CBD-based products will exceed expectations.
CD International’s wealth of international experience and extensive understanding of the workings of Chinese commerce and culture make it an interesting cross market opportunity in both the medical marijuana and Chinese consumer arenas.
For more information, visit the company’s website at www.CDII.net
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com